Showing results (151-160 of 173) with videos related to
Sort By:
Pageof 18
Oral Oncology|February 26, 2026
Efficacy of radiotherapy to metastatic lesion in de novo metastatic nasopharyngeal carcinoma patients: A multicenter, propensity score matching studyZe-Yu Zhao, Shui-Qing He, Guo-Ying Liu, et al.Oral Oncology|October 11, 2024
Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort studyShui-Qing He, Guo-Ying Liu, Ya-Hui Yu, et al.Diabetes & Vascular Disease Research|December 11, 2014
Evaluation of body adiposity index as a predictor of aortic stiffness in multi-ethnic Asian population with type 2 diabetesMei Chung Moh, Chee Fang Sum, Benjamin Chih Chiang Lam, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 21, 2024
Efficacy of local-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score matching studyShui-Qing He, Guo-Ying Liu, Ya-Hui Yu, et al.Redox Biology|February 15, 2020
Tsg101 positively regulates P62-Keap1-Nrf2 pathway to protect hearts against oxidative damageShan Deng, Kobina Essandoh, Xiaohong Wang, et al.Cardiovascular Research|March 6, 2014
Interferon regulatory factor 3 protects against adverse neo-intima formationShu-Min Zhang, Li-Hua Zhu, Zuo-Zhi Li, et al.Nature Communications|May 15, 2025
Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunityXiaosheng Tan, Xiangli Zhao, Zunsong Hu, et al.Nature Communications|May 11, 2026
ACAD8 deficiency promotes pathological cardiac hypertrophy in response to pressure overload by regulating histone isobutyrylationJing-Yi Wang, Xin-Yan Zhao, Xin Sun, et al.Nature Communications|November 29, 2013
TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal deathYan-Yun Lu, Zuo-Zhi Li, Ding-Sheng Jiang, et al.Hypertension (Dallas, Tex. : 1979)|January 8, 2014
Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophyDing-Sheng Jiang, Yu Liu, Heng Zhou, et al.Pageof 18